157 related articles for article (PubMed ID: 10721092)
1. Is there any relationship between eosinophilia myalgia syndrome (EMS) and fibromyalgia syndrome (FMS)? An analysis of clinical and immunological data.
Barth H; Berg PA; Klein R
Adv Exp Med Biol; 1999; 467():487-96. PubMed ID: 10721092
[TBL] [Abstract][Full Text] [Related]
2. L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.
Barth H; Klein R; Berg PA
Clin Exp Immunol; 2001 Nov; 126(2):187-92. PubMed ID: 11703359
[TBL] [Abstract][Full Text] [Related]
3. A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome.
Klein R; Berg PA
Clin Investig; 1994 Jul; 72(7):541-9. PubMed ID: 7981584
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico.
Philen RM; Hill RH; Flanders WD; Caudill SP; Needham L; Sewell L; Sampson EJ; Falk H; Kilbourne EM
Am J Epidemiol; 1993 Aug; 138(3):154-9. PubMed ID: 8356958
[TBL] [Abstract][Full Text] [Related]
5. Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome.
Hudson JI; Pope HG; Carter WP; Daniels SR
J Rheumatol Suppl; 1996 Oct; 46():37-42; discussion 42-3. PubMed ID: 8895180
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in sera from patients with L-tryptophan-associated eosinophilia-myalgia syndrome. Demonstration of unique antigen-antibody specificities.
Kaufman LD; Varga J; Gomez-Reino JJ; Jimenez S; Targoff IN
Clin Immunol Immunopathol; 1995 Aug; 76(2):115-9. PubMed ID: 7542184
[TBL] [Abstract][Full Text] [Related]
7. L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis.
Varga J; Jimenez SA; Uitto J
J Invest Dermatol; 1993 Jan; 100(1):97S-105S. PubMed ID: 8423409
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilia-myalgia syndrome or fibromyalgia with eosinophilia?
Hudson JI; Pope HG; Daniels SR; Horwitz RI
JAMA; 1993 Jun 23-30; 269(24):3108-9. PubMed ID: 8505810
[No Abstract] [Full Text] [Related]
9. Eosinophilia-myalgia syndrome in Germany: an epidemiologic review.
Carr L; Rüther E; Berg PA; Lehnert H
Mayo Clin Proc; 1994 Jul; 69(7):620-5. PubMed ID: 8015323
[TBL] [Abstract][Full Text] [Related]
10. The cause and pathogenesis of the eosinophilia-myalgia syndrome.
Varga J; Uitto J; Jimenez SA
Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618
[TBL] [Abstract][Full Text] [Related]
11. Upper extremity contractures in a patient with eosinophilia-myalgia syndrome.
Marchman HB; Gleason CB; Shaw JC
Arch Phys Med Rehabil; 1991 Nov; 72(12):1029-30. PubMed ID: 1953317
[TBL] [Abstract][Full Text] [Related]
12. High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders.
Klein R; Berg PA
Eur J Med Res; 1995 Oct; 1(1):21-6. PubMed ID: 9392689
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.
Varga J; Maul GG; Jimenez SA
Arthritis Rheum; 1992 Jan; 35(1):106-9. PubMed ID: 1290474
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive dysfunction in the eosinophilia-myalgia syndrome.
Krupp LB; Masur DM; Kaufman LD
Neurology; 1993 May; 43(5):931-6. PubMed ID: 8492948
[TBL] [Abstract][Full Text] [Related]
15. 1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.
Yamaoka KA; Miyasaka N; Inuo G; Saito I; Kolb JP; Fujita K; Kashiwazaki S
J Clin Immunol; 1994 Jan; 14(1):50-60. PubMed ID: 8132737
[TBL] [Abstract][Full Text] [Related]
16. Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan.
Allen JA; Peterson A; Sufit R; Hinchcliff ME; Mahoney JM; Wood TA; Miller FW; Whitfield ML; Varga J
Arthritis Rheum; 2011 Nov; 63(11):3633-9. PubMed ID: 21702023
[TBL] [Abstract][Full Text] [Related]
17. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
[TBL] [Abstract][Full Text] [Related]
18. 1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro.
Zangrilli JG; Mayeno AN; Vining V; Varga J
Biochem Mol Biol Int; 1995 Nov; 37(5):925-33. PubMed ID: 8624499
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and formation of an EMS correlated contaminant in biotechnologically manufactured L-tryptophan.
Müller B; Pacholski C; Simat T; Steinhart H
Adv Exp Med Biol; 1999; 467():481-6. PubMed ID: 10721091
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of case-associated contaminants peak C and FF in L-tryptophan implicated in eosinophilia-myalgia syndrome.
Naylor S; Williamson BL; Johnson KL; Gleich GJ
Adv Exp Med Biol; 1999; 467():453-60. PubMed ID: 10721088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
